Zika Virus Testing Market Drivers, Industry Survey and Business Development Analysis till 2027
28th July 2020 - Global Zika Virus Testing Market
was valued at USD 131.9 million in 2016 and is estimated to grow significantly
due to the growing demand for diagnostics from different parts of the world.
Zika Virus is a disease by mosquitos that targets pregnant ladies especially
the fetus. In 2016, there was a sudden outburst of Zika Virus, which led to a
massive demand for point-of-care testing diagnostic tests.
The diagnostic test is
not location specific with no special requirements for special laboratory setup.
The point-of-care test comprises RT-PCR, serology IgG/IgM Antibody detection,
ELISA and with no laboratory organization. These tests are undertaken in
riskier surroundings, which display harsh symptoms of Zika Virus like fever in
pregnancy along with rashes, muscle pain or joint pain and conjunctivitis. The
disease can be transferred form one individual to another either by sexual
contact or from mother to fetus while pregnancy. The disease prevention
planning and funding therapeutic and is expected to boost the market growth in
the coming years with a CAGR of 7.6%.
Access Zika Virus
Testing Market Report with TOC @ https://www.millioninsights.com/industry-reports/zika-virus-testing-market
No proper vaccination has been found against
Zika Virus till date in spite of the extensive ongoing research; hence to
relieve the symptoms care and comfort is the only way to deal with this
situation. Zika Virus detection kit is available for qualitative tests that are
helpful in detecting RNA of Zika Virus from the body samples like plasma, urine
and serum. After detection of Zika Virus is in the body, antibodies
Immunoglobulin M (IgM) are developed against the virus. The Zika Virus RNA
detection test and the positive serum test for Immunoglobulin M (IgM) are
performed to check and ascertain the presence of Zika Virus in the body.
The research and development activities have
been increased by the leading market players due to the government initiatives
for the emergence of enhanced tests for detecting Zika Virus. The speedy
growing prevalence of Zika Virus testing infection, increasing awareness
regarding early detection and rising efforts by the manufacturers to introduce
Zika Virus detection tests are predicted to drive the market growth. Moreover,
the slow speed of adoption of modern technologies & lack of awareness in
emerging nations and enormous costs of branded test kits are estimated to bring
obstacles in the growth of Zika Virus Testing Market in the near future. Also,
incorrect results from defective diagnostic techniques can affect the Zika
Virus Testing Market.
Currently, the Zika Virus detection is done in
view of clinical manifestations. The serological devices and molecular
detection are also important. Since the segmentation of this virus is
difficult, NASBA, LFAs, and LAMP help in detecting and confirming reason behind
fever. These new techniques have supported in faster and accurate detection of
the virus.
The market is categorized on the basis of test
type, end user and geography. On the basis of test type, the market is divided
into serological tests and molecular diagnostic tests which is also called as
nucleic acid amplification tests. The commonly used test is molecular diagnosis
tests. It is (RT-PCR) Reverse Transcriptase Polymerase Chain Reaction that
detects the existence of the Zika virus in human serum. The serological tests
are dependent on the detection of IgM and IgG antibodies in the human’s serum
by ELISA-based tests. On the basis of end-user, the Zika Virus Testing Market
can be divided into diagnostic & pathological laboratories, contract
research organizations, hospitals, and academic & research institutes.
The
prominent players in the Zika Virus Testing Industry are
ARUP Laboratories, Luminex Corporation, Hologic, Siemens Healthcare Diagnostics
and Roche Molecular Systems.
Request a Sample Copy
of Zika Virus Testing Market Report @ https://www.millioninsights.com/industry-reports/zika-virus-testing-market/request-sample
Geographically, the market is segmented into Latin
America, North America, Asia Pacific, Europe and Middle East & Africa.
North America is expected to dominate the market largely in the coming years
due to the speedy growth of Zika virus in the region. After North America,
Europe is expected to contribute the Zika Virus Testing Market at a significant
pace. The Zika Virus Testing Market in Asia Pacific is predicted to grow in the
coming years owing to the increasing awareness of Zika Virus and the emerging
healthcare industry in the area.
Comments
Post a Comment